跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SIMILASAN EYE DROPS NO2 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SIMILASAN EYE DROPS NO2
Authorized
STANDARD
SIMILASAN EYE DROPS NO2
Similasan AG
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
3cf919e6b8f03066
Company
Similasan AG
Type
Standard
Approval Details
Approval Id
3cf919e6b8f03066
Drug Approval Canada Name
SIMILASAN EYE DROPS NO2
Product Name
SIMILASAN EYE DROPS NO2
Status
Cancelled Post Market
Status Date
2003-11-28
Original Market Date
1996-10-10
Din
00819131
Drug Class
Human
Dosage Form
Liquid
Route Of Administration
Ophthalmic
Schedule
OTC
Ahfs
92:01.00*
Aig Number
0321214001
Company Name
Similasan AG
Company Address
68 Alte Obfelderstrasse, Switzerland, Saone Et Loire, Switzerland, 8910
Company Detail Path
/organization/similasan-ag
Company Information
Pharmaceutical Company Name
Similasan AG
Country Name
Switzerland
Province Name
Aargau
City Name
jonen,aargau,country_ch
Address
Chriesiweg 6
Active Ingredients
SABADILLA
30.148 ML / 100 ML
EUPHRASIA OFFICINALIS
30.148 ML / 100 ML
APIS MELLIFICA
30.148 ML / 100 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
3cf919e6b8f03066
Type
Standard
Back to Health Canada Approvals